Celiac Disease Market and Epidemiology Analysis 2018-2034 with Detailed Profiles of Marketed and Pipeline Drugs, Including KAN-101 (Kanyos Bio) and TIMP-GLIA/TAK 101 (Takeda)
07 juin 2024 09h15 HE
|
Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Celiac Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
Bronchiectasis Opportunity Assessment and 10 Year Forecast 2023-2033
06 juin 2024 09h09 HE
|
Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Bronchiectasis: Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering. This report covers the 8 Major...
Global Immunoglobulin Products Market Report 2024-2028: Increasing Adoption of Subcutaneous Administration and Growing Focus on Personalized Medicine to Lead to Sizable Demand in the Market
04 juin 2024 04h02 HE
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Global Immunoglobulin Products Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The global immunoglobulin products...
Global Tetraspecific Antibodies Clinical Trials & Market Report 2024: Pioneering the Future of Cancer Treatment, Shift Towards Tetraspecific Antibodies Amidst Drug Resistance Challenges
31 mai 2024 04h48 HE
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Global Tetraspecific Antibodies Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's...
Psoriasis Drugs Market (2023-2034) to Grow by $28.85 Billion - Global and Regional Growth Opportunities for Hospital, Retail, and Online Pharmacies with Profiles of the Top 10+ Market Players
30 mai 2024 06h13 HE
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Global Psoriasis Drugs Market" report has been added to ResearchAndMarkets.com's offering.The global psoriasis drugs market accounted for USD 12.41...
Immunology Collaboration and Licensing Agreements Analysis Report 2024 with Directory of Deals Signed Since 2016 - Company A-Z, Therapy Focus and Technology Type
16 mai 2024 10h45 HE
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Immunology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Immunology Collaboration and...
Global Xerostomia Therapeutics Analysis & Forecast to 2024-2034: $3.69 Billion Market Expanding Amid Growing Cases of Parkinson's, Hypertension, and Diabetes
13 mai 2024 05h51 HE
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Global Xerostomia Therapeutics Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
REGN4461 (Mibavademab) for Lipodystrophy in 7MM: Market Size, Sales, Forecasts, and Emerging Insights 2019-2023, 2024-2032
30 avr. 2024 04h31 HE
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "REGN4461 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Innovative Seborrhea Treatments on the Horizon as Pipeline Report Reveals Promising Drug Candidates for 2024
26 avr. 2024 04h36 HE
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Seborrhea - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. Seborrhea, a chronic skin condition often...
Cryopyrin-Associated Periodic Syndrome Drug Pipeline Report 2024: Therapeutic Developments for Zydus Cadila, Novartis, Inflazome, Roche, Aclaris Therapeutics, and Mabpharm
25 avr. 2024 07h43 HE
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Cryopyrin-Associated Periodic Syndrome - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offeringThe global medical...